Deric B.

ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company re-envisioning the treatment of "cold" tumors, particularly of immune-excluded tumors. Immune-excluded tumors, which account for more than half of all cancers, are characterized by having mechanisms of resistance that suppress the immune response; this subgroup is resistant to current immunotherapies. ImmunoGenesis is creating therapies based on the pathology of these immune-excluded tumors that are rationally designed to overcome immune exclusion and thereby drive an effective immune response. We look at cold, immune-excluded tumors through a new lens, re-envisioning treatment with a deliberate drug development strategy based in cold tumor pathology.

The Virtuix Omni™ motion platform enables players to explore endless VR worlds, moving freely and at full speed in 360° without hitting any walls. Walk, run, and turn in 360° in virtual reality games and other applications!

Renovion is a clinical-stage company dedicated to advancing therapies that restore lung health. Our product, ARINA·1, has been developed to change the lives of individuals with a lung transplant, non-cystic fibrosis bronchiectasis (NCFBE), non-tuberculous mycobacteria-lung disease (NTM-LD), and Tracheostomy. *Please note that the Renovion Team is NOT hiring at this time.

Affinity Transit is a family owned business that was established in April of 2014. We started our journey providing services to Burbanks very own Providence Saint Josephs Medical Center and have grown exponentially ever since! We now provide services for almost all major hospital organizations in Los Angeles County including UCLA Health, Cedars Sinai, Providence, and more! We specialize in transporting patients who need assistance getting into their home and/or their desired destination all with professional and courteous care.

ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company re-envisioning the treatment of "cold" tumors, particularly of immune-excluded tumors. Immune-excluded tumors, which account for more than half of all cancers, are characterized by having mechanisms of resistance that suppress the immune response; this subgroup is resistant to current immunotherapies. ImmunoGenesis is creating therapies based on the pathology of these immune-excluded tumors that are rationally designed to overcome immune exclusion and thereby drive an effective immune response. We look at cold, immune-excluded tumors through a new lens, re-envisioning treatment with a deliberate drug development strategy based in cold tumor pathology.

The Virtuix Omni™ motion platform enables players to explore endless VR worlds, moving freely and at full speed in 360° without hitting any walls. Walk, run, and turn in 360° in virtual reality games and other applications!

Renovion is a clinical-stage company dedicated to advancing therapies that restore lung health. Our product, ARINA·1, has been developed to change the lives of individuals with a lung transplant, non-cystic fibrosis bronchiectasis (NCFBE), non-tuberculous mycobacteria-lung disease (NTM-LD), and Tracheostomy. *Please note that the Renovion Team is NOT hiring at this time.